Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia

G. Camussi, F. Bussolino, C. Tetta

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This study reports the results of in vitro and in vivo investigations on the effect of prostacyclin (PGI2) on polymorphonuclear neutrophils (PMN) challenged with immune complexes (IC). In vitro, PGI2 does not affect the interaction of IC with PMN membrane receptors, but prevents the ensuing PMN aggregation and secretion of platelet-activating factor, a lipid mediator responsible for immune-induced PMN aggregation. In vivo, the infusion of PGI2 in New Zealand white rabbits injected with IC prevents IC-induced neutropenia and thrombocytopenia as well as the embolization of PMN into the pulmonary peripheral capillary network. These results suggests a physiological role for PGI2 in modulating the interaction between IC and PMN.

Original languageEnglish
Pages (from-to)625-633
Number of pages9
JournalImmunology
Volume48
Issue number4
Publication statusPublished - 1983

Fingerprint

Epoprostenol
Antigen-Antibody Complex
Neutropenia
Neutrophils
Platelet Activating Factor
Thrombocytopenia
Rabbits
Lipids
Lung
Membranes

ASJC Scopus subject areas

  • Immunology

Cite this

Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. / Camussi, G.; Bussolino, F.; Tetta, C.

In: Immunology, Vol. 48, No. 4, 1983, p. 625-633.

Research output: Contribution to journalArticle

Camussi, G, Bussolino, F & Tetta, C 1983, 'Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia', Immunology, vol. 48, no. 4, pp. 625-633.
Camussi, G. ; Bussolino, F. ; Tetta, C. / Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. In: Immunology. 1983 ; Vol. 48, No. 4. pp. 625-633.
@article{40c2c0c17c424a6983f44fac493a33ee,
title = "Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia",
abstract = "This study reports the results of in vitro and in vivo investigations on the effect of prostacyclin (PGI2) on polymorphonuclear neutrophils (PMN) challenged with immune complexes (IC). In vitro, PGI2 does not affect the interaction of IC with PMN membrane receptors, but prevents the ensuing PMN aggregation and secretion of platelet-activating factor, a lipid mediator responsible for immune-induced PMN aggregation. In vivo, the infusion of PGI2 in New Zealand white rabbits injected with IC prevents IC-induced neutropenia and thrombocytopenia as well as the embolization of PMN into the pulmonary peripheral capillary network. These results suggests a physiological role for PGI2 in modulating the interaction between IC and PMN.",
author = "G. Camussi and F. Bussolino and C. Tetta",
year = "1983",
language = "English",
volume = "48",
pages = "625--633",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia

AU - Camussi, G.

AU - Bussolino, F.

AU - Tetta, C.

PY - 1983

Y1 - 1983

N2 - This study reports the results of in vitro and in vivo investigations on the effect of prostacyclin (PGI2) on polymorphonuclear neutrophils (PMN) challenged with immune complexes (IC). In vitro, PGI2 does not affect the interaction of IC with PMN membrane receptors, but prevents the ensuing PMN aggregation and secretion of platelet-activating factor, a lipid mediator responsible for immune-induced PMN aggregation. In vivo, the infusion of PGI2 in New Zealand white rabbits injected with IC prevents IC-induced neutropenia and thrombocytopenia as well as the embolization of PMN into the pulmonary peripheral capillary network. These results suggests a physiological role for PGI2 in modulating the interaction between IC and PMN.

AB - This study reports the results of in vitro and in vivo investigations on the effect of prostacyclin (PGI2) on polymorphonuclear neutrophils (PMN) challenged with immune complexes (IC). In vitro, PGI2 does not affect the interaction of IC with PMN membrane receptors, but prevents the ensuing PMN aggregation and secretion of platelet-activating factor, a lipid mediator responsible for immune-induced PMN aggregation. In vivo, the infusion of PGI2 in New Zealand white rabbits injected with IC prevents IC-induced neutropenia and thrombocytopenia as well as the embolization of PMN into the pulmonary peripheral capillary network. These results suggests a physiological role for PGI2 in modulating the interaction between IC and PMN.

UR - http://www.scopus.com/inward/record.url?scp=0020645828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020645828&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 625

EP - 633

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 4

ER -